VEGFR1 is expressed by endothelial cells (EC) as well as tumor cells, bone marrow-derived pro-angiogenic and pro-inflammatory cells (mostly monocyte-macrophage lineage cells), vascular smooth muscle cells and by stromal cells such as fibroblasts [110]. Here, FLT1 is linked to neoplasm.